6505--Notice of Intent - AMA Radiopharmaceuticals
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically Network Contracting Office 17, has issued a Special Notice indicating its intent to award a sole source firm-fixed priced order to Panhandle Nuclear RX LTD for radiopharmaceuticals. These items are crucial for patient care at the Amarillo VA Health Care System, Amarillo, TX. Interested parties must submit capability statements by March 25, 2026.
Scope of Work
This procurement covers a wide range of radiopharmaceuticals, including various isotopes of I-123, In-111, Tc-99m, Gallium Citrate, Ultratag RBC Kit, and Co-57 sources. These items are essential for diagnostic and therapeutic procedures at the Amarillo VA. The critical requirement for this sole source justification is the limited shelf-life of these radiopharmaceuticals, necessitating a nuclear pharmacy near the delivery location. The contractor must also be licensed by the US Nuclear Regulatory Commission (USNRC) or an equivalent State agency.
Contract & Timeline
- Opportunity Type: Special Notice / Notice of Intent
- Intended Awardee: Panhandle Nuclear RX LTD
- Contract Type: Firm-Fixed Price Order (anticipated)
- Authority: 41 U.S.C. 3304(a)(1) (only one responsible source)
- Set-Aside: None (sole source)
- Response Due: March 25, 2026 (by 3:00 PM Central Time)
- Published: March 18, 2026
Submission & Evaluation
This notice is not a request for quotations or proposals. However, responsible sources may submit a capability statement, proposal, or quotation within seven days from the publication date (March 18, 2026). Submissions will be considered to determine if a comparable and more advantageous source is available. If no affirmative written response is received by the deadline, the order will be issued to Panhandle Nuclear RX LTD without further notice.
Point of Contact
For inquiries, contact Vance Farrell, Contract Specialist, at vance.farrell@va.gov or 210-694-6379.